A prospective observational study of venous thromboembolism in patients with bone and soft tissue sarcomas in Japan.

A prospective observational study of venous thromboembolism in patients with bone and soft tissue sarcomas in Japan. - Venous thromboembolism cohort study for sarcoma (VTECS)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013495

Enrollment

2000

Registered

2014-03-24

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone and soft tissue sarcoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) histologically diagnosed as bone and soft tissue sarcoma 2) planned to underwent surgical excision at JMOG participants institutes 3) 18 years old or more 4) obtained written informed consent

Exclusion criteria

Exclusion criteria: 1) diagnosed as metastatic or benign musculoskeletal tumor 2) past history of bleeding disorder (deficiencies of protein C, S, AT-III, anti-phospholipid antibody syndrome, and hemophilia) 3) having active infection 4) underwent surgical intervention within 6 months 5) past history of VTE 6) receiving anticoagulant therapy 7) other exclusionary comorbidity

Design outcomes

Primary

Measure	Time frame
The incidence rate of symptomatic VTE at 6 months after the surgery.	—

Secondary

Measure	Time frame
The incidence rate of symptomatic VTE at 7,14,28 days after the surgery. Relationship between the candidate risk factors and the incidence rate of symptomatic VTE.	—

Countries

Japan

Contacts

Public ContactShintaro Iwata

Chiba Cancer Center Division of Orthopedic Surgery

siwata@chiba-cc.jp043-264-5431

Outcome results